Arginine-Supplemented Diet Decreases Expression of Inflammatory Cytokines and Improves Survival in Burned Rats

Abstract

Background: We examined whether the expression of inflammatory cytokines in organs was influenced by the enteral diet supplemented with arginine in burned rats. Methods: Male Wistar rats weighing about 200 g underwent catheter jejunostomy and received scald burns covering 30% of the whole-body surface area. Animals were divided into two groups: a control group (no supplemental arginine, n = 12) and an arginine group (supplemental arginine: 7.7 g/L, n = 10), which continuously received total enteral nutrition for 7 days (250 kcal/kg/d, 1.72 gN/kg/d). The following were measured after the experiment: (1) messenger RNA (mRNA) expression of tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), interleukin-1beta (IL-1β), and IL-6 in the spleen, thymus, lung, and liver by a semiquantitative reverse transcription-polymerase chain reaction method, (2) inflammatory cytokines in the plasma and supernatant of cultured splenic lymphocytes by enzyme-linked immunosorbant assay, (3) nitric oxide (NO) product, NO₂ ^-/NO₃ ^-, in the plasma and supernatant of cultured splenic lymphocytes by the Griess method, and (4) survival rate by the Kaplan-Meier method. Results: The mRNA expression of TNF-α was significantly decreased in the spleen and lung (p < .01, p < .05), IFN-γ in the lung (p < .05), IL-1β in the spleen (p < .05), and IL-6 in the thymus and liver (p < .05, p < .05) in the arginine group when compared with the control group. The production of TNF-α by splenic lymphocytes was suppressed in the arginine group in both concanavalin A (Con A)-treated and -untreated cultures (p < .01, p < .05). The production of IFN-γ by splenic lymphocytes treated with Con A was suppressed in the arginine group (p < .05). The NO product in the supernatant without Con A was increased in the arginine group (p < .05). The mortality rate of the arginine group (0%) was lower than that in the control group (33.3%) on day 7 after the burn injury (p < .05). Conclusions: The data suggest that dietary arginine supplementation decreases the mRNA expression of inflammatory cytokines in organs and improves the survival rate after thermal injury. (Journal of Parenteral and Enteral Nutrition 24:89-96, 2000)

Get full access to this article

View all access options for this article.

References

Foex BA , Shelly MP : The cytokine response to critical illness. J Accid Emerg Med 13:154-162, 1996

Dinarello CA : The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 163:1177-1184, 1991

Zieve L. : Conditional deficiencies of ornithine or arginine. J Am Coll Nutr 5:167-176, 1986

Barbul A. Arginine: Biochemistry, physiology and therapeutic implications. JPEN 10:227-238, 1986

Kirk SJ , Barbul A. : Role of arginine in trauma, sepsis, and immunity. JPEN 14:226S-229S, 1990

Palmer RM : The L-arginine:nitric oxide pathway. Curr Opin Nephrol Hypertens 2:122-128, 1993

Moncada S. , Palmer RM , Higgs EA : Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142, 1991

Tiao G. , Rafferty J. , Ogle C. , et al: Detrimental effect of nitric oxide synthase inhibition during endotoxemia may be caused by high levels of tumor necrosis factor and interleukin-6 . Surgery 116: 332-338, 1994

Fukatsu K. , Saito H. , Fukushima R. , et al: Detrimental effects of a nitric oxide synthase inhibitor (N-ω-nitro-L-arginine-methyl-ester) in a murine sepsis model. Arch Surg 130:410-414, 1995

10.

Christopher TA , Ma XL , Lefer AM : Beneficial actions of S-nitroso-N-acetylpenicillamine, a nitric oxide donor, in murine traumatic shock. Shock 1:19-24. 1994

11.

Saito H. , Trocki O. , Wang SL , et al: Metabolic and immune effects of dietary arginine supplementation after burn. Arch Surg 122: 784-789, 1987

12.

Adjei AA , Yamauchi K. , Nakasone Y. , et al: Arginine-supplemented diets inhibit endotoxin-induced bacterial translocation in mice. Nutrition 11:371-374, 1995

13.

Nakayama H. , Yokoi H. , Fujita J. : Quantification of mRNA by non-radioactive RT-PCR and CCD imaging system. Nucleic Acids Res 20:4939, 1992

14.

Ogle CK , Zuo L. , Mao JX , et al: Differential expression of intestinal and splenic cytokines after parenteral nutrition. Arch Surg 130:1301-1308, 1995

15.

Danas P. , Reuter A. , Gysen P. , et al: Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 17:975-978, 1989

16.

De Bandt JP , Cholet-Martin S. , Herrivann A. , et al: Cytokine response to burn injury: relationship with protein metabolism. J Trauma 36:624-628, 1994

17.

Svoboda P. , Kantorova I. , Ochmann J. : Dynamics of interleukin 1, 2 and 6 and tumor necrosis factor alpha in multiple trauma patients. J Trauma 36:336-340, 1994

18.

O'Riordain MG , O'Riordain DS , Molloy RG , et al: Dosage and timing of anti-TNF-a antibody treatment determine its effect on resistance to sepsis after injury. J Surg Res 64:95-101, 1996

19.

Fisher CJ , Opal SM , Dhainaut JF , et al: Influence of an antitumour necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Crit Care Med 21:318-327, 1993

20.

Souba WW : Cytokine control of nutrition and metabolism during critical illness . Curr Probl Surg 31:586-643, 1994

21.

Fisher CJ , Slotman GJ , Opal SM , et al: Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebo controlled trial. Crit Care Med 22:12-21, 1994

22.

Lowry SF : The route of feeding influences injury responses. J Trauma 30:S10-S15, 1990

23.

Wilmore DW : Catabolic illness. N Engl J Med 325:695-702, 1991

24.

Persoons JHA , Schornagel K. , Tilders FFH , et al: Alveolar macrophages autoregulate IL-1 and IL-6 production by endogenous nitric oxide . Am J Respir Cell Mol Biol 14:272-278, 1996

25.

Wu JZ , Ogle CK , Mao JX , et al: The increased potential for the production of inflammatory cytokines by Kupffer cells and splenic macrophages eight days after thermal injury. Inflammation 19:529-541, 1995

26.

Meldrum DR , Shames BD , Meng X. , et al: Nitric oxide downregulates lung macrophage inflammatory cytokine production. Ann Thorac Surg 66:313-317, 1998

27.

van der Meide PH , de Labie MC , Botman CA , et al: Nitric oxide suppresses IFN-gamma production in the spleen of mercuric chloride-exposed brown Norway rats. Cell Immunol 161 :195- 206, 1995

28.

Iuvone T. , D'Acquisto E. , Carnuccio R. , et al: Nitric oxide inhibits LPS-induced tumor necrosis factor synthesis in vitro and in vivo. Life Sci 59:P L207-L211, 1996

29.

Lin MT , Saito H. , Fukushima R. , et al: Preoperative TPN influences postoperative systemic cytokine responses after colorectal surgery. Nutrition 13:8-12, 1997

30.

Beaumier L. , Castillo L. , Ajami AM , et al: Urea cycle intermediate kinetics and nitrate excretion at normal and "therapeutic" intakes of arginine in humans . Am J Physiol 269:E884-E896, 1995

31.

Hishikawa K. , Nakaki T. , Tsuda M. , et al: Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man . Jpn Heart J 33:41-48, 1992

32.

Kharitonov SA , Lubec G. , Lubec B. , et al: L-Arginine increase exhaled nitric oxide in normal human subjects. Clin Sci (Colch) 88:135-139, 1995

33.

Gianotti L. , Alexander JW , Pyles T. , et al: Arginine-supplemented diets improve survival in gut-derived sepsis and peritonitis by modulating bacterial clearance. The role of nitric oxide. Ann Surg 217:644-654, 1993

34.

Senkal M. , Kemen M. , Homann HH , et al: Modulation of postoperative immune response by enteral nutrition with a diet enriched with arginine, RNA, and omega-3 fatty acids in patients with upper gastrointestinal cancer. Eur J Surg 161: 115-122, 1995